Iowa State Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.14M | Sell |
5,120
-18
| -0.4% | -$18.4K | 1.03% | 32 |
|
|
2026
Q1 | $4.73M | Sell |
5,138
-518
| -9% | -$525K | 0.87% | 38 |
|
|
2025
Q4 | $6.08M | Buy |
5,656
+70
| +1% | +$66.9K | 1.14% | 28 |
|
|
2025
Q3 | $4.26M | Sell |
5,586
-1
| -0% | -$744 | 0.81% | 42 |
|
|
2025
Q2 | $4.36M | Buy |
5,587
+35
| +0.6% | +$27.2K | 0.87% | 39 |
|
|
2025
Q1 | $4.59M | Sell |
5,552
-180
| -3% | -$150K | 0.97% | 35 |
|
|
2024
Q4 | $4.43M | Buy |
5,732
+120
| +2% | +$99.4K | 0.92% | 37 |
|
|
2024
Q3 | $4.97M | Buy |
5,612
+460
| +9% | +$414K | 1.02% | 34 |
|
|
2024
Q2 | $4.66M | Buy |
5,152
+208
| +4% | +$166K | 1.03% | 33 |
|
|
2024
Q1 | $3.85M | Buy |
4,944
+301
| +6% | +$214K | 0.85% | 41 |
|
|
2023
Q4 | $2.71M | Buy |
4,643
+3,513
| +311% | +$2.05M | 0.65% | 56 |
|
|
2023
Q3 | $607K | Hold |
1,130
| – | – | 0.16% | 86 |
|
|
2023
Q2 | $530K | Hold |
1,130
| – | – | 0.13% | 89 |
|
|
2023
Q1 | $388K | Buy |
1,130
+46
| +4% | +$15.5K | 0.1% | 93 |
|
|
2022
Q4 | $397K | Sell |
1,084
-111
| -9% | -$39.4K | 0.1% | 97 |
|
|
2022
Q3 | $386K | Sell |
1,195
-191
| -14% | -$60.5K | 0.11% | 88 |
|
|
2022
Q2 | $449K | Hold |
1,386
| – | – | 0.12% | 90 |
|
|
2022
Q1 | $397K | Sell |
1,386
-90
| -6% | -$23.2K | 0.09% | 96 |
|
|
2021
Q4 | $408K | Sell |
1,476
-40
| -3% | -$10.1K | 0.1% | 98 |
|
|
2021
Q3 | $350K | Hold |
1,516
| – | – | 0.1% | 105 |
|
|
2021
Q2 | $348K | Hold |
1,516
| – | – | 0.1% | 103 |
|
|
2021
Q1 | $283K | Sell |
1,516
-36
| -2% | -$7.04K | 0.09% | 109 |
|
|
2020
Q4 | $262K | Hold |
1,552
| – | – | 0.09% | 110 |
|
|
2020
Q3 | $230K | Sell |
1,552
-40
| -3% | -$6.19K | 0.09% | 108 |
|
|
2020
Q2 | $261K | Sell |
1,592
-2,500
| -61% | -$384K | 0.11% | 95 |
|
|
2020
Q1 | $568K | Hold |
4,092
| – | – | 0.27% | 78 |
|
|
2019
Q4 | $538K | Hold |
4,092
| – | – | 0.19% | 92 |
|
|
2019
Q3 | $458K | Buy |
+4,092
| New | +$456K | 0.17% | 92 |
|
|
2019
Q2 | – | Sell |
-1,592
| Closed | -$207K | – | 107 |
|
|
2019
Q1 | $207K | Sell |
1,592
-255
| -14% | -$31K | 0.1% | 99 |
|
|
2018
Q4 | $214K | Sell |
1,847
-254
| -12% | -$28.4K | 0.11% | 97 |
|
|
2018
Q3 | $225K | Buy |
+2,101
| New | +$210K | 0.1% | 95 |
|
|
2017
Q3 | – | Sell |
-2,521
| Closed | -$207K | – | 96 |
|
|
2017
Q2 | $207K | Buy |
+2,521
| New | +$206K | 0.1% | 92 |
|
|
2015
Q4 | – | Sell |
-2,724
| Closed | -$228K | – | 90 |
|
|
2015
Q3 | $228K | Buy |
+2,724
| New | +$230K | 0.16% | 73 |
|
Other funds holding LLY
SC
Iowa State Bank's LLY Position: Q2 2026 in Review
Iowa State Bank reduced its Eli Lilly (LLY) stake by 0.35% in Q2 2026, selling an estimated $18.4K and leaving 5,120 shares worth $6.14M. The position accounts for 1.03% of the portfolio, ranked #32.
Iowa State Bank first reported a position in LLY in Q3 2015 and has held it in 33 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Iowa State Bank held 5,120 shares of Eli Lilly worth $6.14M as of Q2 2026.
- Iowa State Bank sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
- Eli Lilly made up 1.03% of Iowa State Bank's portfolio in Q2 2026, its #32 holding.
- Iowa State Bank first reported a position in Eli Lilly in Q3 2015 and has held it in 33 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Iowa State Bank's 13F filing for Q2 2026, filed 28 Jul 2026.